Does DINUTUXIMAB Cause Capillary leak syndrome? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Capillary leak syndrome have been filed in association with DINUTUXIMAB (Unituxin). This represents 4.9% of all adverse event reports for DINUTUXIMAB.
33
Reports of Capillary leak syndrome with DINUTUXIMAB
4.9%
of all DINUTUXIMAB reports
6
Deaths
19
Hospitalizations
How Dangerous Is Capillary leak syndrome From DINUTUXIMAB?
Of the 33 reports, 6 (18.2%) resulted in death, 19 (57.6%) required hospitalization, and 7 (21.2%) were considered life-threatening.
Is Capillary leak syndrome Listed in the Official Label?
Yes, Capillary leak syndrome is listed as a known adverse reaction in the official FDA drug label for DINUTUXIMAB.
What Other Side Effects Does DINUTUXIMAB Cause?
Pyrexia (144)
Off label use (95)
Neuroblastoma recurrent (76)
Pain (74)
Abdominal pain (60)
Hypotension (55)
Neuroblastoma (49)
Anaemia (47)
Aspartate aminotransferase increased (46)
Alanine aminotransferase increased (43)
What Other Drugs Cause Capillary leak syndrome?
GEMCITABINE (134)
TAGRAXOFUSP-ERZS (110)
PACLITAXEL (97)
CYCLOPHOSPHAMIDE (86)
DOCETAXEL (81)
CYTARABINE (68)
METHOTREXATE (65)
NIVOLUMAB (61)
RITUXIMAB (58)
FILGRASTIM (52)
Which DINUTUXIMAB Alternatives Have Lower Capillary leak syndrome Risk?
DINUTUXIMAB vs DINUTUXIMAB BETA
DINUTUXIMAB vs DIOSMIN
DINUTUXIMAB vs DIOSMIN\HESPERIDIN
DINUTUXIMAB vs DIOVAN
DINUTUXIMAB vs DIOVAN HCT